๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Many people with type 2 diabetes cannot maintain target blood glucose level...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-03
Trial ID
NCT00106340
Treatments Being Tested
Type 2 diabetes is epidemic and its treatment has become more and more diff...
Status
Unknown
Location
Katherine Esposito
Start Date
2005-10
Trial ID
NCT02142309
Treatments Being Tested
GIOIA represents a multicenter pragmatic prospective cohort study, aimed at...
Status
Completed
Location
Unit of Diabetes
Start Date
2018-01-15
Trial ID
NCT03918148
Despite advances in diabetes management, many patients with type 2 diabetes...
Status
Completed
Location
Department of endocrinology, FAH-SYSU
Start Date
2019-05-01
Trial ID
NCT03958591
Study subjects will be randomly assigned to the three groups and receive th...
Status
Active Not Recruiting
Location
Center Hospital of the National Center for Global Health and Medicine
Start Date
2022-05-26
Trial ID
NCT05366868
Treatments Being Tested
The purpose of this study is to compare the effect of a single administrati...
Status
Completed
Location
UH Toulouse
Start Date
2010-10
Trial ID
NCT01452113
Treatments Being Tested
Dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagonlike peptide-1 (GLP-1...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01
Trial ID
NCT01518101
Treatments Being Tested
This study is not being conducted in the United States. This is a 52-week e...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-07
Trial ID
NCT00138593
Treatments Being Tested
This study is not being conducted in the United States. Vildagliptin is an ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-04
Trial ID
NCT00325429
Treatments Being Tested
This is a 52-week extension to a study to assess the safety and effectivene...
Status
Completed
Location
Novartis Investigative Site
Start Date
2005-01
Trial ID
NCT00138567
Treatments Being Tested